Expanding the ethical debate on human artificial placenta trials

Artificial placentas (APs) are technologies that mimic the human placenta to treat extremely preterm infants. Being an invasive and risky technology, it will raise important ethical questions for human trials. Hence, in this Topic Piece we provide a blueprint of further issues to investigate. First,...

Full description

Saved in:
Bibliographic Details
Main Authors: Alice Cavolo, Daniel Pizzolato
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Research Ethics Review
Online Access:https://doi.org/10.1177/17470161241259127
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841561003051974656
author Alice Cavolo
Daniel Pizzolato
author_facet Alice Cavolo
Daniel Pizzolato
author_sort Alice Cavolo
collection DOAJ
description Artificial placentas (APs) are technologies that mimic the human placenta to treat extremely preterm infants. Being an invasive and risky technology, it will raise important ethical questions for human trials. Hence, in this Topic Piece we provide a blueprint of further issues to investigate. First, counselling will have the double role of providing trial information as well as (non) treatment counselling. This requires extra training and the development of ad hoc decision aids to support counselling and parents’ decision-making. Second, more stakeholder involvement is needed. Direct stakeholders, such as parents, clinicians, and researchers, can help develop the decision aids and provide insight on potentially overlooked issues. Society should also be involved to determine whether AP trials and implementation should be subsidized, and the ethical implications of not subsidizing. Third, a proper cost-benefit analysis should be conducted to determine the exact cost of the technology.
format Article
id doaj-art-e1842e2cebb7492ebd3bff1b630bd4b9
institution Kabale University
issn 1747-0161
2047-6094
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Research Ethics Review
spelling doaj-art-e1842e2cebb7492ebd3bff1b630bd4b92025-01-03T09:03:24ZengSAGE PublishingResearch Ethics Review1747-01612047-60942025-01-012110.1177/17470161241259127Expanding the ethical debate on human artificial placenta trialsAlice CavoloDaniel PizzolatoArtificial placentas (APs) are technologies that mimic the human placenta to treat extremely preterm infants. Being an invasive and risky technology, it will raise important ethical questions for human trials. Hence, in this Topic Piece we provide a blueprint of further issues to investigate. First, counselling will have the double role of providing trial information as well as (non) treatment counselling. This requires extra training and the development of ad hoc decision aids to support counselling and parents’ decision-making. Second, more stakeholder involvement is needed. Direct stakeholders, such as parents, clinicians, and researchers, can help develop the decision aids and provide insight on potentially overlooked issues. Society should also be involved to determine whether AP trials and implementation should be subsidized, and the ethical implications of not subsidizing. Third, a proper cost-benefit analysis should be conducted to determine the exact cost of the technology.https://doi.org/10.1177/17470161241259127
spellingShingle Alice Cavolo
Daniel Pizzolato
Expanding the ethical debate on human artificial placenta trials
Research Ethics Review
title Expanding the ethical debate on human artificial placenta trials
title_full Expanding the ethical debate on human artificial placenta trials
title_fullStr Expanding the ethical debate on human artificial placenta trials
title_full_unstemmed Expanding the ethical debate on human artificial placenta trials
title_short Expanding the ethical debate on human artificial placenta trials
title_sort expanding the ethical debate on human artificial placenta trials
url https://doi.org/10.1177/17470161241259127
work_keys_str_mv AT alicecavolo expandingtheethicaldebateonhumanartificialplacentatrials
AT danielpizzolato expandingtheethicaldebateonhumanartificialplacentatrials